Symposium will address and discuss the main challenges arising from recent advancements in life sciences. New technologies like stem cell research, artificial organoids and genome editing have raised enormous expectations within the biomedical research community, patients and the general public. At the same time many ethical questions have emerged and a need to be discussed in an open dialogue.
Its aim is to foster a dialogue on ethical up-to-date issues like data sharing, biobanking, genome editing, stem cell and organoid research and raise awareness for responsible research.
The goal is to bridge biotechnological research and relevant ethical aspects as well as to foster an interdisciplinary dialogue, and to highlight best practice examples.
Among the speakers, there will be:
Christiane Druml, Head of the Austrian Bioethics Commission and UNESCO Chair in Bioethics
"Bioethics in Austria – structures and content"
Annelien Bredenoord, Utrecht University
"Ethical challenges arising from organoid research"
Carol Smee, Regulatory & Ethical Compliance Manager, Sanger Institute, Cambridge
"Regulation of iPSC research – a UK research institute's perspective"
Sarion Bowers, Policy Lead, Sanger Institute, Cambridge
"Mechanisms and principles of data sharing"
Johannes Starkbaum, University of Vienna
"Ethical challenges arising from biobanks"
Ulrich Körtner, University of Vienna
"Theological Aspects of Bioethics"
Date: April 5th, 2017.
Venue: Lecture Hall, Institute of Molecular Biotechnology, Dr. Bohr-Gasse 3, 1030 Vienna, Austria.
The bioethics symposium at IMBA will address the scientific community and opinion leaders from diverse fields, and is also open to the public.
Registration is open until April 4th 2017.